Devrim Kilinc

Lille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Non-microglial downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease-related hallmarks.

Non-microglial downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease-related hallmarks.

Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026

BIN1 gain-of-function in the presynaptic compartment leads to isoform-specific synaptotoxicity.

BIN1 gain-of-function in the presynaptic compartment leads to isoform-specific synaptotoxicity.

Journal: Alzheimer's research & therapy
Published: September 18, 2025

Inflammatory stimulus enhances synaptic material uptake by adult APP microglia in a microfluidic neuron-microglia co-culture model.

Inflammatory stimulus enhances synaptic material uptake by adult APP microglia in a microfluidic neuron-microglia co-culture model.

Journal: Journal of neuroinflammation
Published: September 05, 2025

The structure of an amyloid precursor protein/talin complex indicates a mechanical basis of Alzheimer's disease.

The structure of an amyloid precursor protein/talin complex indicates a mechanical basis of Alzheimer's disease.

Journal: Open biology
Published: November 26, 2024

BIN1 and Alzheimer's disease: the tau connection.

BIN1 and Alzheimer's disease: the tau connection.

Journal: Trends in neurosciences
Published: November 14, 2024

Calpain and caspase regulate Aβ peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2.

Calpain and caspase regulate Aβ peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2.

Journal: Neurobiology of aging
Published: July 04, 2024

The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC-derived neurons to amyloid beta and phosphorylated tau-induced neuronal dysfunction.

The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC-derived neurons to amyloid beta and phosphorylated tau-induced neuronal dysfunction.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: June 01, 2024

PLCG2 downregulation impairs synaptic function and increases Alzheimer's disease hallmarks in neuronal cultures.

PLCG2 downregulation impairs synaptic function and increases Alzheimer's disease hallmarks in neuronal cultures.

Journal: Nature genetics
Published: May 17, 2024

Nifuroxazide rescues the deleterious effects due to CHCHD10-associated MICOS defects in disease models.

Nifuroxazide rescues the deleterious effects due to CHCHD10-associated MICOS defects in disease models.

Journal: Brain : a journal of neurology
Published: February 23, 2024

Integration of Microfluidic Devices with Microelectrode Arrays to Functionally Assay Amyloid-β-Induced Synaptotoxicity.

Integration of Microfluidic Devices with Microelectrode Arrays to Functionally Assay Amyloid-β-Induced Synaptotoxicity.

Journal: ACS biomaterials science & engineering
Published: February 22, 2024

Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice.

Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice.

Journal: Brain : a journal of neurology
Published: November 30, 2023

High-Content Screening of Synaptic Density Modulators in Primary Neuronal Cultures.

High-Content Screening of Synaptic Density Modulators in Primary Neuronal Cultures.

Journal: Current protocols
Published: October 26, 2023
Showing 1-12 of 36

Last Updated: 09/26/2026